| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.03 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |